Hepatitis C Stocks List

Related Stock Lists: Biotechnology Biopharmaceutical Chemical Compounds Chemistry Chronic And Life Threatening Conditions Medication Alcohols Anti Infectives Biology Cac All Share Index Chemotherapy Clinical Applications Cyclopropanes Drugs Dry Eye Disease FDA Gene Expression Genetic Engineering Genetics HCV Infection

Recent Signals

Date Stock Signal Type
2020-06-03 BNTC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-06-03 ENTA 50 DMA Resistance Bearish
2020-06-03 ENTA Shooting Star Candlestick Bearish
2020-06-03 ENTA Doji - Bearish? Reversal
2020-06-03 ENTA 180 Bearish Setup Bearish Swing Setup
2020-06-03 ENTA 20 DMA Resistance Bearish
2020-06-03 SCYX Bollinger Band Squeeze Range Contraction
2020-06-03 SCYX Fell Below 20 DMA Bearish
2020-06-03 UTHR Upper Bollinger Band Walk Strength
2020-06-03 UTHR MACD Bullish Signal Line Cross Bullish
2020-06-03 UTHR New 52 Week Closing High Bullish
2020-06-03 UTHR Stochastic Reached Overbought Strength
2020-06-03 UTHR New 52 Week High Strength
2020-06-03 XTLB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-06-03 XTLB Narrow Range Bar Range Contraction
2020-06-03 XTLB Calm After Storm Range Contraction

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. The virus persists in the liver in about 75% to 85% of those initially infected. Early on chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, needlestick injuries in healthcare, and transfusions. Using blood screening, the risk from a transfusion is less than one per two million. It may also be spread from an infected mother to her baby during birth. It is not spread by superficial contact. It is one of five known hepatitis viruses: A, B, C, D, and E. Diagnosis is by blood testing to look for either antibodies to the virus or its RNA. Testing is recommended in all people who are at risk.There is no vaccine against hepatitis C. Prevention includes harm reduction efforts among people who use intravenous drugs and testing donated blood. Chronic infection can be cured about 95% of the time with antiviral medications such as sofosbuvir or simeprevir. Peginterferon and ribavirin were earlier generation treatments that had a cure rate of less than 50% and greater side effects. Getting access to the newer treatments however can be expensive. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation.An estimated 143 million people (2%) worldwide are infected with hepatitis C as of 2015. In 2013 about 11 million new cases occurred. It occurs most commonly in Africa and Central and East Asia. About 167,000 deaths due to liver cancer and 326,000 deaths due to cirrhosis occurred in 2015 due to hepatitis C. The existence of hepatitis C – originally identifiable only as a type of non-A non-B hepatitis – was suggested in the 1970s and proven in 1989. Hepatitis C infects only humans and chimpanzees.

More about Hepatitis C